In this article, we will break down and analyze BioCryst Pharmaceuticals, Inc.. We will also be looking over the current market data to help you assess whether or not it is a good investment for you. While this isn’t a golden ticket to successful investing, you can use these metrics as powerful tools for your decision making.” & D1 & “opened this morning at $11.93 and has moved $0.06 from yesterday’s closing price of $11.87. Today’s high is $12.19 and the low is $11.78. A great indicator of where a stock is trending is by looking at its 52-week high/low. This is a technical indicator used by some traders and investors who view these figures as an important factor in the analysis of a stock’s current value and as a predictor of its future price movement. They also use this data to determine an investments credit rating.
The 52-week high for BioCryst Pharmaceuticals, Inc. is $18.48 and the low is $6.83. We will be moving onto the number of outstanding shares. One is that you can use shares outstanding to calculate the market capitalization, the total value, of a corporation. Multiply the price of a single stock by the number of shares outstanding to find a business’s market capitalization. The number of outstanding shares for BioCryst Pharmaceuticals, Inc. is 178870000. Now that you know more about BioCryst Pharmaceuticals, Inc. stands, let’s learn more about the future of the company.
As an investor, you can get an idea of where the stock is trending by the forecast and beta. Beta is calculated using regression analysis. A beta of 1 indicates that the security’s price tends to move with the market. A beta greater than 1 indicates that the security’s price tends to be more volatile than the market. A beta of less than 1 means it tends to be less volatile than the market. BioCryst Pharmaceuticals, Inc. has a beta of 0.6. Knowing all of this, we project that BioCryst Pharmaceuticals, Inc. will have a price of $15.509 in 12-months compared to its current price of $11.93. We can also take a look at the company’s market cap. Market cap is important because it allows investors to understand the relative size of one company versus another. Market cap measures what a company is worth on the open market, as well as the market’s perception of its prospects because it reflects what investors are willing to pay for its stock. BioCryst Pharmaceuticals, Inc. has a market cap of $2146637727.
Stock analysis is a method for investors and traders to make buying and selling decisions. Investors and traders try to gain an edge in the markets by making informed decisions through analyzing the past and current data. The ultimate goal is to arrive at a number that can be compared to the present price of a security to determine whether it is undervalued or overvalued. View the chart below to get a better understanding of how the stock has been moving.